Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Êàêèå íóæíû àíàëèçû?
    îò furex â ðàçäåëå Çäîðîâüå êîæè, äåðìàòîëîã
    Îòâåòîâ: 50
    : 28.09.2004, 16:57
  2. Îòâåòîâ: 1
    : 18.08.2004, 22:44
  3. Îòâåòîâ: 2
    : 28.07.2004, 17:51
  4. Êàê ìîæíî îïðåäåëèòü ãèïåðàíäðîãåíèþ, êàêèå äëÿ ýòîãî íóæíû àíàëèçû?...
    îò Àíîíèì â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 1
    : 26.06.2004, 04:44
  5. Óâàæàåìûé äîêòîð, ïîäñêàæèòå, ïîæàëóéñòà, êàêèå àíàëèçû íóæíû äëÿ îïðåäåëåí...
    îò Àííà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 1
    : 12.05.2004, 11:21
  1. Melnichenko
    #31
    ×èòàòåëü Íåäóã.Ðó
    Êàæäàé èç íàñ áåç îñîáîãî òðóäà ìîæåò ïîëó÷èòü èíîôðìàöèþ î ïðèïàðàòàõ, ïðèìåíÿþùèõñÿ äëÿ ëå÷åíèÿ àíäðîãåí-çàâèñèìîé äåðìàòîïàòèè, íî èç ýòîãî îòíþäü íå ñëåäóåò íåîáõîäèìîëñòü èçó÷åíèÿ "ãîðìîíàëüíîé ïàíåëè". Èñêëþ÷åíèå æå ïåðâè÷íûõ ýíäîêðèíîïàòèé íå òðåáóåò âûõîäà íà ïàíåëü, à áàçèðóåòñÿ íà âïîëíå âìåíÿåìûõ ìåòîäàõ îáñëåäîâàíèÿ- âíå çàâèñèìîñòè îò êîëè÷åñòâà äåòåé ó òðèõîëîãà.

     öåëîì ñîçäàåòñÿ âïå÷àòëåíèå, ÷òî íåñëîæíàÿ èäåÿ ðåöåïòîðîâ, ôåðìåíòîâ è ãåíîâ êàêèì-òî îáðàçîì îñòàëàñü âíå ïîëÿ çðåíèÿ òîâ. òèðõîëãîâ, ãëóáîêî óáåæäåíûõ â íåêîåì âûñøåì ñìûñëå "ãîðìîíàëüíîé ïàíåëè" - õîòü áû óçíàòü, êòî â íåå âõîäèò è ÷òî èç ýòîãî âûõîäèò- äëÿ ïðèíÿòèÿ íåïîñèëüíîãî ïî ñìåëîñòè ðåøåíèÿ î íàçíà÷åíèè îäíîãî èç 2 ñ ïîëîâèíîé ðåêëàìèðóåìûõ ïðåïàðàòîâ.

  2. Íàòàëüÿ Ï.
    #32
    ×èòàòåëü Íåäóã.Ðó
    Òàéíû âïåðåìåæêó ñ ïîó÷åíèÿìè.

    Ïî÷åìó áû Âàì íå äàòü ññûëêè? Çà÷åì â ëè÷êó? Ïóñòü è äðóãèå ëþäè ó÷àòñÿ. Äëÿ ýòîãî è ôîðóì.

  3. Light
    #33
    ×èòàòåëü Íåäóã.Ðó
    Äà íå â "î÷êàõ" äåëî. Äàëèñü Âàì ýòè î÷êè! Åñëè Âû ñïåöèàëèñò è õîòèòå êîíñòðóêòèâíîãî ðàçãîâîðà ñ êîëëåãàìè è ïëîäîòâîðíûõ áåñåä ñ ïàöèåíòàìè - âåäèòå íîðìàëüíóþ áåñåäó, íîðìàëüíóþ äèñêóññèþ. Êàêîé ñìûñë âñå âðåìÿ èñêàòü êîíôëèêòîâ, îñêîðáëÿÿ êîëëåã? Íå êðàñèâî ýòî.

    Âû íà ýòîì ôîðóìå íèêîìó åù¸ íå ïîìîãëè.

    Ïðîÿâèëè æèâîé èíòåðåñ òîëüêî ê æèòåëüíèöå Óêðàèíû (ìîë, îòêóäà Âû?) - êëèåíòîâ çäåñü âûèñêèâàåòå, ÷òî ëè?

  4. volos
    #34
    ×èòàòåëü Íåäóã.Ðó
    Âîò Âàì, óâàæàåìàÿ light, è îòâåò îò ïðîôåññîðà Ìåëüíè÷åíêî.×òî-òî ìíå ïîäñêàçûâàåò, ÷òî ýòî ñëîâî "ïàíåëü" êàêîå-òî áîëåçíåííîå..÷òî-òî ÿâíî àññîöèàòèâíîå..À Âàì, óâàæàåìàÿ ïðîôåññîð Ìåëüíè÷åíêî, íå æàëü äåíþæåê íà îïëàòó èíòåðíåòà, äîðîãîñòîÿùåãî ëè÷íîãî âðåìåíè íà ýòó ñëîâåñíóþ çëîáíóþ øåëóõó? Íå íóæíî òðÿñòè ïåðüÿìè - àëîïåöèÿ ïðèêëþ÷èòñÿ. Âû æ âðåìåíè íå äàåòå íà êîíñòðóêòèâíóþ ïîëåìèêó!

    Óâàæàåìûå êîëëåãè! Êðîìå àíäðîãåíåòè÷åñêîé àëîïåöèè åñòü åùå ðÿä òåì ïî î÷àãîâîé-òîòàëüíîé è äèôôóçíî-ñèìïòîìàòè÷åñêîé. Õîòåëà áû îáñóäèòü ñ Âàìè îïûò ïðèìåíåíèÿ â êîìïëåêñíîé òåðàïèè êàíòåïàðèíà, à â íàðóæíîé íîâîãî ïðåïàðàòà - EUCAPIL.

  5. Melnichenko
    #35
    ×èòàòåëü Íåäóã.Ðó
    Èðèíà, îòêóäà ó Âàñ ñòîëüêî çëîáû ?



    Ðå÷ü èäåò î òîì, ÷òî ëþîå èññëåäîâàíèå äîëæíî áûòü îïðàâäàííûì. Òåðìèíû æå 'ãîðìîíàëüíàÿ ïàíåëü, ãîðìîíàëüíîå çåðêàëî è ãîðìîíàëüíûé ïðîôèëü " ìîãóò âûçûâàòü òîëüêî óäèâëåíèå.



    Âðÿä ëè ñòîèò çàáûâàòü, ÷òî Âû ðàçãîâàðèâàåòå ñ êîëëåãàìè ñ êóäà áîëüøèì ñòàæåì ðàáîòû, ÷åì Âû,è, áîþñü. ñ íåñêîëüêî áîëüøèìè çíàíèÿìè - âî âñÿêîì ñëó÷àå, â îáëàñòè ýíäîêðèíîëîãèè.



    ×åñòíî ãîâðÿ, ìåíÿ èçóìëÿåò Âàøà ðåêàöèÿ- ÿ íå ãîâîðþ íè÷åãî òàêîãî, ÷òî áûëî áû íåèçâåñòíî- â ÷åì ïðîáëåìà ?

  6. Light
    #36
    ×èòàòåëü Íåäóã.Ðó
    ×òî-òî ìíå ïîäñêàçûâàåò, ÷òî ýòî ñëîâî "ïàíåëü" êàêîå-òî áîëåçíåííîå..÷òî-òî ÿâíî àññîöèàòèâíîå..À Âàì, óâàæàåìàÿ ïðîôåññîð Ìåëüíè÷åíêî, íå æàëü äåíþæåê íà îïëàòó èíòåðíåòà, äîðîãîñòîÿùåãî ëè÷íîãî âðåìåíè íà ýòó ñëîâåñíóþ çëîáíóþ øåëóõó? Íå íóæíî òðÿñòè ïåðüÿìè - àëîïåöèÿ ïðèêëþ÷èòñÿ.

    Âû îòâðàòèòåëüíî ãðóáû, Èðèíà. Óâàæàòü Âàñ ïîñëå ýòîãî, êàê êîëëåãó, è, âîçìîæíî, íåïëîõîãî ïðîôåññèîíàëà, íå ïðåäñòàâëÿåòñÿ âîçìîæíûì.

    Âû æ âðåìåíè íå äàåòå íà êîíñòðóêòèâíóþ ïîëåìèêó!

    Óâàæàåìûå êîëëåãè! Êðîìå àíäðîãåíåòè÷åñêîé àëîïåöèè åñòü åùå ðÿä òåì ïî î÷àãîâîé-òîòàëüíîé è äèôôóçíî-ñèìïòîìàòè÷åñêîé. Õîòåëà áû îáñóäèòü ñ Âàìè îïûò ïðèìåíåíèÿ â êîìïëåêñíîé òåðàïèè êàíòåïàðèíà, à â íàðóæíîé íîâîãî ïðåïàðàòà - EUCAPIL.

    Ïî óêàçàííûì íàçâàíèÿì - ìîðå èíôîðìàöèè â è-íåòå. Êàíòåïàðèí - ÁÀÄ. Íå èíòåðåñíî. EUCAPIL - ïîäðîáíî çäåñü:

    http://www.eucapil.com/xhtml_en/eucapil.shtml

  7. volos
    #37
    ×èòàòåëü Íåäóã.Ðó
    Èðîíèÿ è çëîáà - ðàçíûå ïîíÿòèÿ. Âû óñîìíèëèñü -ÿ ïðåäñòàâèëàñü. Áóðÿ â ñòàêàíå âîäû èç-çà õîëåñòåðèíà? Âû äàæå íå äîñëóøàëè..ß íå î ñòàæå, ÿ-îá îïûòå. Ïî ïîâîäó " íèêîìó íå ïîìîãëè" - âåñüìà ñïîðíî.Îïûòíûå äåðìàòîëîãè-òðèõîëîãè Ðîññèè ñþäà äàæå íå çàõîäÿò - íàïðàñíûé òðóä.Êëèåíòîâ èñêàòü? Çäåñü??? Íó, ïðàâî, êàê äåòè.. ß ïîäîæäó, ïîêà âñå æåëàþùèå âûãîâîðÿòñÿ è ñïóñòÿò ïàð â ìîþ ñòîðîíó è íà÷íåòñÿ äèàëîã. Äîãîâîðèëèñü?

    Êîãî íåâîëüíî çàäåëà èëè îáèäåëà-ÑÎÐÐÈ! Î÷åíü óæ ïîõîæå íà ñèòóàöèþ áåëîé âîðîíû â ÷óæîé ñòàå. Ñ óäîâîëüñòâèåì ïîñëóøàþ ñîâåòû ñòàðøèõ, íå ïðèåìëþ òîëüêî êàòåãîðè÷íîñòè - ïðèçíàê íåâåæåñòâà è ãëóïîñòè. Ñïàñèáî âñåì, ñ óâàæåíèåì, Èðèíà.

  8. TREE
    #38
    ×èòàòåëü Íåäóã.Ðó
    òàê "êàêèå àíàëèçû íóæíî ñäàòü" òî? )

  9. volos
    #39
    ×èòàòåëü Íåäóã.Ðó
    [ ß íå êîíñóëüòèðóþ íà"îêîëîìåäèöèíñêèõ" ôîðóìàõ, åäèíñòâåííûé ôîðóì , ãäå ïðàêòè÷åñêè êàæäàÿ êîíñóëüòàöèÿ îí-ëàéí çàêàí÷èâàåòñÿ ñëîâàìè " îáðàòèòåñü ê ñïåöèàëèñòó.." -ýòî likar.info... è òî, ðåäêî âåñüìà.

    Æàëü ïîòðà÷åííîãî Âàøåãî âðåìåíè, Hard, íà ìîþ ñêðîìíóþ ïåðñîíó.

    Ñâîåãî ìíå íå æàëü-âûõîäíûå äíè.. äà è "ëèöî" ðàçäåëà ïðîÿñíèëîñü êàê íåëüçÿ êñòàòè.

  10. rodionov
    #40
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìàÿ Èðèíà Àëåêñååâíà!

    Íó âî-ïåðâûõ çäåñü íåò àíîíèìîâ. Âñå âðà÷è ôîðóìà âûñòóïàþò ïîä ñâîèìè ôàìèëèÿìè, èõ ìåñòà ðàáîòû èçâåñòíû. Íàïðèìåð, ùåëêíóâ ìûøüþ ïî ìîåé ïîäïèñè, Âû óçíàåòå îá ó÷ðåæäåíèè, ãäå ÿ èìåþ ÷åñòü ðàáîòàòü, òàì æå åñòü èíôîðìàöèÿ î ñîòðóäíèêàõ.

    Âî-âòîðûõ, çäåñü âñå âðà÷è, ïðåæäå âñåãî âðà÷è, íåçàâèñèìî îò ñïåöèàëüíîñòè (êñòàòè, õèðóðãîâ ÿ ïîêà òóò íå âèæó ), êîòîðûå òàê èëè èíà÷å ñòàëêèâàþòñÿ ñ ïðîáëåìàìè àëîïåöèè.

    Â-òðåòüèõ, îòêðûòîå îáñóæäåíèå ìåäèöèíñêèõ ïðîáëåì ñîîáùà - ýòî íîðìàëüíàÿ ïðàêòèêà. Ôîðóì íå òîëüêî êîíñóëüòàòèâíûé, îí åùå è äèñêóññèîííûé. Åñëè Âàñ ñìóùàåò, ÷òî âñ¸ ïðîèñõîäèò â òåìå, íà÷àòîé ïàöèåíòîì, ìîæíî îòêðûòü äðóãîé òîïèê.

    À âîò íàñ÷åò öåëåñîîáðàçíîñòè íàçíà÷åíèÿ ÁÀÄîâ - ïîãëÿäèòå ôîðóì, ñòîëüêî óæå êîïåé ñëîìàíî íà ýòó òåìó..



    È íå íàäî ïóãàòü ñâîèì óõîäîì. ×òî-òî âû íà ïàðó ñ çåìëÿêîì-Åâãåíèåì, "óõîæó, ïðîùàþñü, ïðåêðàùàþ".. Íèêòî æ îñîáî íå äåðæèò...



    Íó à åñëè Âû âñ¸ æå çàõîòèòå ñ ïîðîãà âåðíóòüñÿ, òî ïðåäëàãàþ íà÷àòü îáñóæäåíèå ñ âîïðîñà (â òðåòèé ðàç óæå): "Çà÷åì ëûñîìó õîëåñòåðèí". Ìîæíî îòäåëüíóþ òåìó ñäåëàòü

  11. Dr. Vad
    #41
    ×èòàòåëü Íåäóã.Ðó
    ...ïðåäëàãàþ íà÷àòü îáñóæäåíèå ñ âîïðîñà (â òðåòèé ðàç óæå): "Çà÷åì ëûñîìó õîëåñòåðèí". Ìîæíî îòäåëüíóþ òåìó ñäåëàòü



    Óâàæàåìûé Àíòîí Âëàäèìèðîâè÷,



    â öåëÿõ ðàçâèòèÿ Âàìè ïðåäëàãàåìîé äèñêóññèè (êðîìå òåõ ìàòåðèàëîâ, êîòîðûå óæå ðàçìåùàë ðàíåå), áîëåå ðàííèé îáçîð ýïèä. íàáëþäåíèé:



    J Clin Epidemiol. 1990;43(11):1255-60.

    Is baldness a risk factor for coronary artery disease? A review of the literature.

    Herrera CR, Lynch C.

    Division of General Internal Medicine, University of Texas Health Science Center, Houston 77030.



    A literature search identified eight articles containing data on both baldness and coronary artery disease (CAD). Three of these articles described case-control studies that showed a positive relationship between baldness and CAD when controlling for CAD risk factors. Three other case-control studies showed no such relationship, but these did not control for CAD risk factors. The results of two cohort studies were inconclusive. Insufficient data were available from these studies to analyze possible relationships between baldness and CAD risk factors themselves. Overall, the data reviewed suggest that a small risk of CAD due to baldness may exist, but this risk is smaller than that of well-known CAD risk factors such as smoking and hypertension. Future research should emphasize proper control for age and CAD risk factors.



    A òàê æå ðàçüÿñíÿëêè îò àâòîðîâ ýòîé ðàáîòû:



    Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE.

    Male pattern baldness and coronary heart disease: the Physicians' Health Study.

    Arch Intern Med. 2000 Jan 24;160(2):165-71.





    In our discussion of possible mechanisms that may explain the observed association between male pattern baldness and the increased risk of CHD, we mentioned elevated androgen levels. As we cited in our article, there is a consistent body of evidence from both laboratory and human studies implicating elevated androgen levels in several aspects of atherogenesis. While testosterone is the most abundant androgen in the plasma of men, dihydrotestosterone may also be involved in these pathways. For example, dihydrotestosterone, which has been implicated in male pattern baldness, has far greater mitogenic activity than testosterone in vascular smooth muscle cells isolated from rat aorta.



    Several studies have documented that the administration of high doses of exogenous androgens as well as use of anabolic steroids resulted in dyslipidemia, elevated blood pressure, and an enhanced tendency for thrombosis. The results of our study suggested that the misuse of androgens and androgen precursors may have more long-term harmful effects than previously recognized.



    After our article was submitted for publication, Signorello et al published an intriguing cross-sectional study among men older than 65 years that corroborated an association between vertex baldness and higher testosterone levels and described a positive association between vertex baldness and insulin-like growth factor 1. Among individuals with essential hypertension, elevated levels of insulin-like growth factor 1 have been associated with left ventricular hypertrophy, a powerful independent predictor of cardiovascular morbidity and mortality. Thus, it is possible that hormones other than androgens may explain the association between vertex baldness and CHD.



    We also discussed non–androgen-related mechanisms in our article. Genetic factors are a possibility, as suggested by a similar pattern of inheritance for male pattern baldness and polycystic ovary syndrome, a common familial condition in women characterized by elevated androgen levels. Women with this syndrome (whose brothers have an increased prevalence of male pattern baldness) are likely to have an adverse cardiovascular risk profile and an increased risk of subclinical atherosclerosis.



    More research is clearly needed to elucidate the apparent link between male pattern baldness and the risk of cardiovascular disease. Regardless of the mechanisms involved, male pattern baldness appears to serve as a marker for the increased risk of cardiovascular disease. Men with this condition may benefit from vigilant attention to prevention efforts directed toward known modifiable risk factors for CHD.



    Arch Intern Med. 2000;160:2064-2065.



    òî åñòü àìåðèêàíñêèå ïðåäïîëîæåíèÿ ïðîñòûå - ïðèøåë ëûñûé íà ïðèåì - ïîäîçðåâàòü êàê ïîòåíöèàëüíîãî íîñèòåëÿ ÈÁÑ, à åñëè åùå ÀÄ è õîëåñòåðèí ïîâûøåíû, òî ëå÷èòü àêòèâíî è áåç âñÿêèõ íàáëþäåíèé.



    Îõ óæ, ýòèì ëûñûì (â îòëè÷èå îò ðûæèõ) è â ýòîì íå ïîâåçëî.

  12. volos
    #42
    ×èòàòåëü Íåäóã.Ðó
    Ñïàñèáî ÂÑÅÌ, êòî ïðèíèìàë ó÷àñòèå â îáñóæäåíèè. Äîëæíà çàìåòèòü, ÷òî PR äëÿ ìåíÿ ïîëó÷èëñÿ íó ïðîñòî òàêè çàìå÷àòåëüíûé! À, ïîñêîëüêó, ó íàñ åñòü ñâîé ñàéò - äàæå âäâîéíå.

    Èñêðåííå æàëü, ÷òî Âàì íåâåäîìû ñòðàõè íàøèõ ïàöèåíòîâ, èõ íàäåæäû,îò÷àÿâøèåñÿ ãëàçà èç-ïîä ïàðèêîâ è íàêëàäîê.. Òåïåðü Âàì ìîæíî ñïàòü ñïîêîéíî - ê Âàì óæ òî÷íî îíè íå ïîïàäóò.

  13. volos
    #43
    ×èòàòåëü Íåäóã.Ðó
    Ïðèÿòíûõ ñíîâèäåíèé, Rodionov, 1992 ãîäà ðîæäåíèÿ.

    Âîçìîæíî, â æèçíè Âû ïðèÿòíûé ñîáåñåäíèê è, áåçóñëîâíî, ãðàìîòíûé äîêòîð.À âîò èìåíè-îò÷åñòâà, ê ñîæàëåíèþ, ÿ íå óçíàþ íèêîãäà..

    Òåì íå ìåíåå, 17-19 ñåíòÿáðÿ â Êèåâå áóäåò ïðîõîäèòü Ìåæäóíàðîäíûé ñèìïîçèóì ïî òðèõîëîãèè . Ñ ñåòêîé äîêëàäîâ ìîãó îçíàêîìèòü âñåõ ïðèñóòñòâóþùèõ.Ýòî , êîíå÷íî , íå áóäåò êîíöåðòîì áàðäîâñêîé ïåñíè è äàæå íå òóðïîõîäîì , íî âñå æå ìîæåò ïðåäñòàâëÿòü èíòåðåñ.

  14. rodionov
    #44
    ×èòàòåëü Íåäóã.Ðó
    À ÿ åùå íå ëîæóñü õîòÿ â Ìîñêâå íà ÷àñ ïîçæå, ÷åì íà Óêðàèíå.

    Ñåðâåð óñòàíàâëèâàåò 1992 ãîä ðîæäåíèÿ ïî óìîë÷àíèþ, êîãäà ã.ð. íå âíåñåí â áàçó. Âû äàëåêî íå ïåðâûé ÷åëîâåê, èðîíèçèðóþùèé ïîäîáíûì îáðàçîì.

    Èìÿ-îò÷åñòâî ÿ ñîâñåì äàæå íå ñêðûâàþ Ìåíÿ çîâóò Àíòîí Âëàäèìèðîâè÷; ÿ æå ïðåäëàãàë Âàì êëèêíóòü ïî ìîåé ôàìèëèè â ïîäïèñè è ïðîñìîòðåòü ñïèñîê ñîòðóäíèêîâ - ïðîñòîé àëãîðèòì ïîèñêà èíôîðìàöèè. Ðàâíî êàê è èíôîðìàöèþ îá îñòàëüíûõ ó÷àñòíèêàõ ôîðóìà ìîæíî íàéòè, îíà íå ñåêðåòíà, ïðîñòî íå âñåãäà âûëîæåíà ÿâíûì îáðàçîì.



    Óâàæàåìàÿ Èðèíà Àëåêñååâíà, Ìåæäóíàðîäíûé ñèìïîçèóì ïî òðèõîëîãèè - ýòî ïðåêðàñíî, Âû âïîëíå ìîæåòå âûëîæèòü ïðîãðàììó íà ôîðóìå.

    Íî æàëü, ÷òî ìû òàê è íå ðåøèëè ïðîáëåìó îïðåäåëåíèÿ ñûâîðîòî÷íîãî õîëåñòåðèíà ïðè àëîïåöèè

  15. Aminazinka
    #45
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìàÿ Èðèíà Àëåêñååâíà!

    Íàäîñëåäîê. Âû, êîíå÷íî, ñâåòèëî òðèõîëîãèè... íàâåðíîå, î÷åíü ìîæåò áûòü. Íó åñëè Âàì òàê íðàâèòñÿ. Íî åñòü äâà ïóíêòà, áëàãîäàðÿ êîòîðûì â íàøåé êîìïàíèè Âàì ïðèæèòüñÿ íå óäàëîñü.

    Ôàêòîð ïåðâûé: Âû òàê è íå óäîñóæèëèñü îòâåòèòü íà âîïðîñû ïðîôåññèîíàëîâ. Îòâåòèòü òàê, ÷òîáû ïðîôåññèîíàëû ïîíÿëè, ÷òî Âû çàíèìàåòåñü ÷åì-òî, ÷òî ñëóæèò èíûì öåëÿì, êðîìå Âàøåãî äîõîäà.

    Ôàêòîð âòîðîé: Î÷åíü ïîõîæå íà òî, ÷òî Âû è íå ñòðåìèòåñü áûòü ÷ëåíîì ñîîáùåñòâà âðà÷åé, Âû ïðåäïî÷ëè âëèòüñÿ â äðóæíóþ è íåáåäíóþ ñåìåéêó ðàñïðîñòðàíèòåëåé ÁÀÄîâ ñ ìåäèöèíñêèìè äèïëîìàìè. Î òîì, ïî÷åìó âðà÷è íà÷èíàþò çàðàáàòûâàòü ïèùåâûìè ïðîäóêòàìè, çäåñü (â äðóãèõ òåìàõ) ìíîãî íàïèñàíî, óãëóáëÿòüñÿ â òåìó íå áóäåì. Âàæíî òî, ÷òî òåïåðü ëþáîå óïîìèíàíèå Âàñ èëè Âàøèõ ïðîäóêòîâ ïîä Âàøåé ïîäïèñüþ èíòåðåñóþùèõñÿ è ïîëüçóþùèõñÿ ïîèñêîâèêàìè áóäåò ïðèâîäèòü è â ýòó òåìó. Ëè÷íî ÿ ýòîìó ðàäà. Íèêîãäà íå ëèøíå óçíàòü ìíåíèå, îòëè÷àþùååñÿ îò ìíåíèÿ ðåêëàìîäàòåëÿ.

    Òåìà çàêðûòà.

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •